Back

ESMO-TAT 2022 - ESMO Targeted Anticancer Therapies Congress 2022: "The Home of Phase I in Oncology"

Mar 07 - Mar 09, 2022 | ParisFrance

LARVOL is not affiliated with ESMO Targeted Anticancer Therapies Congress 2022: "The Home of Phase I in Oncology" and all trademarks, logos, and brand names are property of their respective owners

Showing 13 abstracts linked to Trials

55P - Potential benefits of extensive genomic analysis in patients with KRAS mutated solid tumors; concurrent alterations and potential targets

  • E-Poster, On-demand